The science of fresh starts, with change expert Katy Milkman
‘Fresh Starts’ are a powerful tool for making change. So to kick off 2025, Katy Milkman stops by to give us science-backed strategies for reaching our...
Replay: Plant-based foods need a makeover, with Peter McGuinness
In this special holiday replay, we share another standout conversation from 2024 featuring Impossible Foods’ Peter McGuinness. This year, sustainabili...
Replay: How Fawn Weaver blitzscaled a bourbon brand
This week, we’re revisiting a stellar episode from 2024 with Fawn Weaver, founder of Uncle Nearest Premium Whiskey. Fawn joins host Jeff Berman to sha...
Replay: How Barstool Sports’ ex-CEO cooks up attention, with Food52’s Erika Ayers Badan
In this special holiday replay, we share a standout conversation of 2024 featuring ex-CEO of Barstool and current head of Food52, Erika Ayers Badan. S...
What Dungeons & Dragons can teach entrepreneurs, with Reid Hoffman and Hasbro CEO Chris Cocks
Dungeons & Dragons, the tabletop role-playing game, turns 50 this year. As a lifelong lover of the game, host Reid Hoffman asked fellow D&D pl...
Six lessons of Rapid Response for 2025
We’ve rounded up the most definitive business lessons of 2024, as heard on Rapid Response. Drawn from standout guests like will.i.am, Airbnb’s Brian C...
Prepare for a ‘technology supercycle,’ with futurist Amy Webb
As the founder and CEO of the Future Today Institute, Amy Webb helps global companies and governments see what comes next. She’s an expert in strategi...
Rapid Response: Bluesky’s bold plan beyond the ‘X-odus’, with COO Rose Wang
Millions of users have joined social media platform Bluesky in recent weeks, as an alternative to Elon Musk's X. It’s sparking new opportunities and c...
How The Flex Company founder Lauren Wang disrupted menstrual care
Lauren Wang, founder of The Flex Company, is transforming the menstrual product industry with bold innovations and a tendency to break taboos. Driven ...
Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky
With the help of co-founder Mark Cuban, Cost Plus Drugs CEO Alex Oshmyansky is radically re-engineering the pharma marketplace and dramatically cuttin...